Stock Ratings / Financials / BME / financials

BSTZ (51) NXP (59) VMO (59) NDMO (59) ⌘ Pro Terminal →

Blackrock Health Sciences Trust (BME) Revenue-to-Profit Sankey Flow & SEC XBRL Financials

$46.74 +1.70% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot)

Blackrock Health Sciences Trust (BME) carries a Roarable Rating of D+ (Sell) with 53/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D+ • SELL / AVOID Cap $623.2M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERSELL / AVOID • D+

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D · Rk D+

Each axis scored 0–20

12M PRICE TARGET CONE-2.2% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for BME)Realized 20D OHLCV Swing Band: ±3.6%

VISUAL REVENUE-TO-PROFIT SANKEY WATERFALL • Trailing 12 Months

How BME Turns Every Dollar of Sales Into Real Bottom-Line Profit

Free Cash Flow:$17.4M (0.4% FCF Margin)

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring BME)

✓Walkthrough of BME's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

BME // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +18.87%📐 HORIZONTAL RANGE

2026-10-30O $47.10H $47.38L $46.55C $46.74VOL 65.6K

RES: $49.22SUP: $42.35SMA50: $44.84SMA200: $42.07

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

BME Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 BME Butterfly Map → + Track BME →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on BME today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for BME. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for BME today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (BME)

Financials Rank #741 of 1096 ⚔️ BSTZ vs BME Full Matrix →

1. Head-to-Head Financials Peer Comparison (BME vs. BSTZ, NXP, VMO, NDMO)

Industry: Trusts Except Educational Religious and Charitable (32 Tracked Issuers)

Across 1096 tracked Financials securities in the Roarable RQD universe, Blackrock Health Sciences Trust (BME) ranks #741 by composite RQD confidence (53/100, grade D+) and #658 by equity capitalization ($623.2M). Within this direct 5-issuer industry benchmark cohort, BME leads on earnings valuation at N/A trailing P/E, while BME leads on capital efficiency and profitability with — ROIC and — gross margin. NXP currently holds the highest overall quantitative score in the immediate peer group at 59/100 (C-) compared with BME at 53/100 (D+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
BME ACTIVE Blackrock Health Sciences Trust	D+	53/100	—	—	—	+1.70%	$623.2M	Benchmark Subject
BSTZ BlackRock Science and Technology Term Trust of	D	51/100	—	—	—	-0.49%	$627.5M	/bstz-vs-bme →
NXP Nuveen Select Tax Free Income Portfolio	C-	59/100	—	—	—	+1.21%	$629.0M	/nxp-vs-bme →
VMO Invesco Municipal Opportunity Trust	C-	59/100	—	—	—	+1.12%	$607.0M	/vmo-vs-bme →
NDMO Nuveen Dynamic Municipal Opportunities Fund of	C-	59/100	—	—	—	+1.10%	$546.5M	/ndmo-vs-bme →

2. BME Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics

TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOT

Blackrock Health Sciences Trust (BME) operates in Trusts Except Educational Religious and Charitable (Financials) with an equity capitalization of $623.2M, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.

3. BME Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is BME stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Blackrock Health Sciences Trust (NYSE: BME) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 53/100 at a spot price of $46.74 (+1.70% 1D, market cap $623.2M). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 10/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 9/20. Across 1096 tracked Financials issuers, BME ranks #741 in composite RQD confidence.

How does BME compare to BSTZ and NXP in the Financials sector?

Within the Financials sector (Trusts Except Educational Religious and Charitable), BME carries a Roarable D+ (53/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, BSTZ (BlackRock Science and Technology Term Trust of) holds a D grade (51/100 RQD, P/E N/A, ROIC —, cap $627.5M) and NXP (Nuveen Select Tax Free Income Portfolio) posts a C- grade (59/100 RQD, P/E N/A, ROIC —, cap $629.0M). Among the 5-stock peer group, BME leads on earnings multiple (N/A) while BME leads on capital efficiency (— ROIC).

What are the biggest fundamental strengths and SEC risk factors for BME?

For Blackrock Health Sciences Trust (BME), key quantitative strengths include Established market leader in Financials with deep daily trading liquidity. and sector rank #741 in Financials, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is BME trading relative to its 50-day, 200-day, and 52-week technical levels?

BME last traded at $46.74 (+1.70% on volume of 50,892 shares), positioning the stock +4.24% above its 50-day simple moving average ($44.84) and +11.10% above its 200-day simple moving average ($42.07). Across its 52-week range of $37.51 to $47.38, BME sits at the 93.5% percentile with a 14-day RSI of 68.4 (BULLISH MOMENTUM) and an implied next-earnings move of ±3.6% ($45.06 to $48.42).

BME Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

How profitable is Blackrock Health Sciences Trust (BME)?

In Trailing 12 Months, BME converted $4.0B of revenue into a 52% gross margin, 27% operating margin, and $17.4M in free cash flow (0.4% FCF margin).

Direct Sub-Reports: BME RQD Cockpit BME 12M Forecast BME Earnings & Move BME Dividends & DRIP BME Insiders & 13F BME Whale Options BME Profit Sankey BME News & Why